Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.0055.88%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 673.30K | 1.19M | 1.52M | 2.05M | 2.55M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 6.90K | 6.90K | 6.90K | 6.90K | 6.90K |
| Prepaid Expenses | 60.10K | 41.20K | 5.40K | 4.00K | 14.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 740.30K | 1.24M | 1.53M | 2.06M | 2.57M |
|
|
|||||
| Total Current Assets | 740.30K | 1.24M | 1.53M | 2.06M | 2.57M |
| Net Property, Plant & Equipment | 130.80K | 145.20K | 125.00K | 173.90K | 162.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.20K | 7.20K | 3.50K | 3.50K | 3.50K |
| Total Assets | 1.51M | 2.03M | 2.22M | 2.77M | 3.23M |
|
|
|||||
| Total Accounts Payable | 798.20K | 514.40K | 516.20K | 509.50K | 929.60K |
| Total Accrued Expenses | 7.15M | 7.15M | 3.26M | 3.14M | 6.26M |
| Short-term Debt | 1.62M | 1.62M | 1.62M | 1.64M | 1.65M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 46.90K | 57.50K | 57.50K | 56.70K | 41.80K |
| Total Finance Division Other Current Liabilities | -- | -- | 3.69M | 3.61M | -- |
| Total Other Current Liabilities | -- | -- | 3.69M | 3.61M | -- |
| Total Current Liabilities | 9.61M | 9.34M | 9.15M | 8.96M | 8.89M |
|
|
|||||
| Total Current Liabilities | 9.61M | 9.34M | 9.15M | 8.96M | 8.89M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.62M | 1.62M | 1.62M | 1.64M | 1.65M |
| Capital Leases | 40.50K | 42.50K | 45.40K | 58.00K | 54.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.66M | 9.38M | 9.19M | 9.01M | 8.94M |
|
|
|||||
| Common Stock & APIC | 39.68M | 39.62M | 39.59M | 38.69M | 38.74M |
| Retained Earnings | -53.09M | -52.23M | -51.80M | -50.19M | -49.69M |
| Treasury Stock & Other | 22.00K | 22.00K | -- | 22.00K | 22.00K |
| Total Common Equity | -13.39M | -12.59M | -12.21M | -11.48M | -10.93M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 5.24M | 5.24M | 5.24M | 5.24M | 5.22M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 5.24M | 5.24M | 5.24M | 5.24M | 5.22M |
|
|
|||||
| Total Common Equity | -13.39M | -12.59M | -12.21M | -11.48M | -10.93M |
| Total Preferred Equity | 5.24M | 5.24M | 5.24M | 5.24M | 5.22M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.15M | -7.36M | -6.97M | -6.24M | -5.71M |
|
|
|||||